Goncalves J, Borges T, Souza A
Front Immunol. 2022; 13:889945.
PMID: 35603203
PMC: 9122122.
DOI: 10.3389/fimmu.2022.889945.
Lockhart A, Mucida D, Parsa R
Immunity. 2022; 55(5):800-818.
PMID: 35545029
PMC: 9257994.
DOI: 10.1016/j.immuni.2022.04.007.
Connor R, Brickley E, Wieland-Alter W, Ackerman M, Weiner J, Modlin J
Mucosal Immunol. 2021; 15(1):1-9.
PMID: 34239028
PMC: 8732262.
DOI: 10.1038/s41385-021-00428-0.
Tan S, Granados A, Bouquet J, Hoy-Schulz Y, Green L, Federman S
Sci Rep. 2020; 10(1):15392.
PMID: 32958861
PMC: 7506025.
DOI: 10.1038/s41598-020-71791-4.
Perspect Med Virol. 2020; 1:127-186.
PMID: 32287579
PMC: 7134062.
DOI: 10.1016/S0168-7069(08)70012-0.
Interventions to improve oral vaccine performance: a systematic review and meta-analysis.
Church J, Parker E, Kirkpatrick B, Grassly N, Prendergast A
Lancet Infect Dis. 2019; 19(2):203-214.
PMID: 30712836
PMC: 6353819.
DOI: 10.1016/S1473-3099(18)30602-9.
Oral polio vaccine response in the MAL-ED birth cohort study: Considerations for polio eradication strategies.
Pan W, Seidman J, Ali A, Hoest C, Mason C, Mondal D
Vaccine. 2018; 37(2):352-365.
PMID: 30442479
PMC: 6325791.
DOI: 10.1016/j.vaccine.2018.05.080.
Lymphoid tissue fibrosis is associated with impaired vaccine responses.
Kityo C, Makamdop K, Rothenberger M, Chipman J, Hoskuldsson T, Beilman G
J Clin Invest. 2018; 128(7):2763-2773.
PMID: 29781814
PMC: 6025977.
DOI: 10.1172/JCI97377.
Causes of impaired oral vaccine efficacy in developing countries.
Parker E, Ramani S, Lopman B, Church J, Iturriza-Gomara M, Prendergast A
Future Microbiol. 2017; 13:97-118.
PMID: 29218997
PMC: 7026772.
DOI: 10.2217/fmb-2017-0128.
Effect of human rotavirus vaccine on severe diarrhea in African infants.
Madhi S, Cunliffe N, Steele D, Witte D, Kirsten M, Louw C
Malawi Med J. 2016; 28(3):108-114.
PMID: 27895844
PMC: 5117000.
Biomarkers of Environmental Enteropathy are Positively Associated with Immune Responses to an Oral Cholera Vaccine in Bangladeshi Children.
Uddin M, Islam S, Nishat N, Hossain M, Rafique T, Rashu R
PLoS Negl Trop Dis. 2016; 10(11):e0005039.
PMID: 27824883
PMC: 5100882.
DOI: 10.1371/journal.pntd.0005039.
A spatial model of Wild Poliovirus Type 1 in Kano State, Nigeria: calibration and assessment of elimination probability.
McCarthy K, Chabot-Couture G, Shuaib F
BMC Infect Dis. 2016; 16(1):521.
PMID: 27681708
PMC: 5041410.
DOI: 10.1186/s12879-016-1817-3.
Factors determining anti-poliovirus type 3 antibodies among orally immunised Indian infants.
Kaliappan S, Venugopal S, Giri S, Praharaj I, Karthikeyan A, Babji S
Vaccine. 2016; 34(41):4979-4984.
PMID: 27566901
PMC: 5038128.
DOI: 10.1016/j.vaccine.2016.08.032.
Probiotics, antibiotics and the immune responses to vaccines.
Praharaj I, John S, Bandyopadhyay R, Kang G
Philos Trans R Soc Lond B Biol Sci. 2015; 370(1671).
PMID: 25964456
PMC: 4527389.
DOI: 10.1098/rstb.2014.0144.
Exploring the role of environmental enteropathy in malnutrition, infant development and oral vaccine response.
Gilmartin A, Petri Jr W
Philos Trans R Soc Lond B Biol Sci. 2015; 370(1671).
PMID: 25964455
PMC: 4527388.
DOI: 10.1098/rstb.2014.0143.
Pediatric small intestine bacterial overgrowth in low-income countries.
Donowitz J, Petri Jr W
Trends Mol Med. 2014; 21(1):6-15.
PMID: 25486880
PMC: 4402728.
DOI: 10.1016/j.molmed.2014.11.001.
Eradicating poliomyelitis: India's journey from hyperendemic to polio-free status.
John T, Vashishtha V
Indian J Med Res. 2013; 137(5):881-94.
PMID: 23760372
PMC: 3734678.
Immunogenicity and efficacy of oral vaccines in developing countries: lessons from a live cholera vaccine.
Levine M
BMC Biol. 2010; 8:129.
PMID: 20920375
PMC: 2958895.
DOI: 10.1186/1741-7007-8-129.
The anti-vaccination movement and resistance to allergen-immunotherapy: a guide for clinical allergists.
Behrmann J
Allergy Asthma Clin Immunol. 2010; 6(1):26.
PMID: 20843332
PMC: 2949815.
DOI: 10.1186/1710-1492-6-26.
Escape in four categories.
Walton J
Br Med J. 2010; 1(6175):1413-4.
PMID: 20792854
PMC: 1598911.
DOI: 10.1136/bmj.1.6175.1413.